Alzheimer’s disease is a prevalent form of dementia, impacting memory and cognitive functions and increasing the risk of death. It can disrupt careers, financial planning for retirement, and diminish the quality of life in later years. Researchers at Temple University’s Alzheimer’s Center are investigating ABCA7, a protective protein associated with Alzheimer’s disease. While genome studies initially highlighted its relevance, the study aims to understand its functions and develop therapies. Low ABCA7 levels in the brain are linked to a higher Alzheimer’s risk, suggesting the protein’s protective role. The research investigates how cholesterol and inflammation affect ABCA7 levels, potentially shedding light on disease development and new therapies.
Welcome to Our Weekly Magazine
Become the best version of yourself Sign-up for our weekly magazine.
Become the best version of yourself today.
We send a weekly roundup of our best work and highlight standout community members. It's free, and you can always leave if it's not your jam.
New Discovery in Alzheimer’s Disease & Treatment
See medical disclaimer below.
The ideas expressed here are solely the opinions of the author and are not researched or verified by AGEIST LLC, or anyone associated with AGEIST LLC. This material should not be construed as medical advice or recommendation, it is for informational use only. We encourage all readers to discuss with your qualified practitioners the relevance of the application of any of these ideas to your life. The recommendations contained herein are not intended to diagnose, treat, cure or prevent any disease. You should always consult your physician or other qualified health provider before starting any new treatment or stopping any treatment that has been prescribed for you by your physician or other qualified health provider. Please call your doctor or 911 immediately if you think you may have a medical or psychiatric emergency.